Coûts et analyse des coûts : Questions médicales fréquentes
Nom anglais: Costs and Cost Analysis
Descriptor UI:D003365
Tree Number:N03.219.151
Termes MeSH sélectionnés :
Visual Acuity
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Coûts et analyse des coûts : Questions médicales les plus fréquentes",
"headline": "Coûts et analyse des coûts : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Coûts et analyse des coûts : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-26",
"dateModified": "2025-04-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Coûts et analyse des coûts"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Économie",
"url": "https://questionsmedicales.fr/mesh/D004467",
"about": {
"@type": "MedicalCondition",
"name": "Économie",
"code": {
"@type": "MedicalCode",
"code": "D004467",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.219"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ventilation des coûts",
"alternateName": "Cost Allocation",
"url": "https://questionsmedicales.fr/mesh/D003361",
"about": {
"@type": "MedicalCondition",
"name": "Ventilation des coûts",
"code": {
"@type": "MedicalCode",
"code": "D003361",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.219.151.080"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Analyse coût-bénéfice",
"alternateName": "Cost-Benefit Analysis",
"url": "https://questionsmedicales.fr/mesh/D003362",
"about": {
"@type": "MedicalCondition",
"name": "Analyse coût-bénéfice",
"code": {
"@type": "MedicalCode",
"code": "D003362",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.219.151.125"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maîtrise des coûts",
"alternateName": "Cost Control",
"url": "https://questionsmedicales.fr/mesh/D003363",
"about": {
"@type": "MedicalCondition",
"name": "Maîtrise des coûts",
"code": {
"@type": "MedicalCode",
"code": "D003363",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.219.151.160"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Économies",
"alternateName": "Cost Savings",
"url": "https://questionsmedicales.fr/mesh/D017046",
"about": {
"@type": "MedicalCondition",
"name": "Économies",
"code": {
"@type": "MedicalCode",
"code": "D017046",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.219.151.160.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Analyse coût-efficacité",
"alternateName": "Cost-Effectiveness Analysis",
"url": "https://questionsmedicales.fr/mesh/D000094703",
"about": {
"@type": "MedicalCondition",
"name": "Analyse coût-efficacité",
"code": {
"@type": "MedicalCode",
"code": "D000094703",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.219.151.285"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Activités d'investissement des hôpitaux",
"alternateName": "Capital Expenditures",
"url": "https://questionsmedicales.fr/mesh/D002201",
"about": {
"@type": "MedicalCondition",
"name": "Activités d'investissement des hôpitaux",
"code": {
"@type": "MedicalCode",
"code": "D002201",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.219.151.450.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Soins de faible valeur",
"alternateName": "Low-Value Care",
"url": "https://questionsmedicales.fr/mesh/D000090222",
"about": {
"@type": "MedicalCondition",
"name": "Soins de faible valeur",
"code": {
"@type": "MedicalCode",
"code": "D000090222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.219.151.725"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Coûts et analyse des coûts",
"alternateName": "Costs and Cost Analysis",
"code": {
"@type": "MedicalCode",
"code": "D003365",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "James Lomas",
"url": "https://questionsmedicales.fr/author/James%20Lomas",
"affiliation": {
"@type": "Organization",
"name": "University of York, York, United Kingdom (J.L.)."
}
},
{
"@type": "Person",
"name": "Eric D Shah",
"url": "https://questionsmedicales.fr/author/Eric%20D%20Shah",
"affiliation": {
"@type": "Organization",
"name": "Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. Electronic address: eric.d.shah@hitchcock.org."
}
},
{
"@type": "Person",
"name": "David D Kim",
"url": "https://questionsmedicales.fr/author/David%20D%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St, Box 063, Boston, MA, 02111, USA. dkim3@tuftsmedicalcenter.org."
}
},
{
"@type": "Person",
"name": "Madison C Silver",
"url": "https://questionsmedicales.fr/author/Madison%20C%20Silver",
"affiliation": {
"@type": "Organization",
"name": "Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St, Box 063, Boston, MA, 02111, USA."
}
},
{
"@type": "Person",
"name": "Natalia Kunst",
"url": "https://questionsmedicales.fr/author/Natalia%20Kunst",
"affiliation": {
"@type": "Organization",
"name": "Department of Health Management and Health Economics, University of Oslo, Oslo, Norway."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The prognostic implication of visual acuity at the time of uveal melanoma diagnosis.",
"datePublished": "2022-11-24",
"url": "https://questionsmedicales.fr/article/36434284",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41433-022-02316-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of macular OCT and OCTA parameters with visual acuity in glaucoma.",
"datePublished": "2022-09-09",
"url": "https://questionsmedicales.fr/article/36126109",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bjo-2022-321460"
}
},
{
"@type": "ScholarlyArticle",
"name": "Successful Aging in Assisted Living: The Importance of Near Visual Acuity.",
"datePublished": "2022-09-01",
"url": "https://questionsmedicales.fr/article/36007216",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3928/00989134-20220805-01"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterization of vision in pediatric retinoblastoma survivors beyond visual acuity.",
"datePublished": "2023-07-12",
"url": "https://questionsmedicales.fr/article/37442536",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jaapos.2023.06.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "The speed acuity test as a diagnostic aid in cerebral visual impairment.",
"datePublished": "2022-06-22",
"url": "https://questionsmedicales.fr/article/35732797",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-14673-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Organisations et économie des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D004472"
},
{
"@type": "ListItem",
"position": 3,
"name": "Économie",
"item": "https://questionsmedicales.fr/mesh/D004467"
},
{
"@type": "ListItem",
"position": 4,
"name": "Coûts et analyse des coûts",
"item": "https://questionsmedicales.fr/mesh/D003365"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Coûts et analyse des coûts - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Coûts et analyse des coûts",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Coûts et analyse des coûts",
"description": "Comment évaluer les coûts d'un diagnostic médical ?\nQuels facteurs influencent le coût d'un diagnostic ?\nQuelles sont les méthodes d'analyse des coûts ?\nComment les coûts de diagnostic varient-ils selon les régions ?\nQuel est l'impact des technologies sur les coûts de diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D003365?mesh_terms=Visual+Acuity&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Coûts et analyse des coûts",
"description": "Les symptômes influencent-ils les coûts des soins ?\nComment évaluer le coût des symptômes chroniques ?\nQuels symptômes entraînent des coûts élevés ?\nLes symptômes psychologiques augmentent-ils les coûts ?\nComment les symptômes affectent-ils la productivité ?",
"url": "https://questionsmedicales.fr/mesh/D003365?mesh_terms=Visual+Acuity&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Coûts et analyse des coûts",
"description": "Quels sont les coûts des programmes de prévention ?\nComment évaluer l'efficacité économique de la prévention ?\nQuels programmes de prévention sont les plus rentables ?\nComment la prévention impacte-t-elle les coûts de santé ?\nQuels facteurs influencent le coût des initiatives préventives ?",
"url": "https://questionsmedicales.fr/mesh/D003365?mesh_terms=Visual+Acuity&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Coûts et analyse des coûts",
"description": "Comment analyser les coûts des traitements médicaux ?\nQuels traitements sont les plus coûteux ?\nComment les traitements préventifs influencent-ils les coûts ?\nQuel est l'impact des nouvelles thérapies sur les coûts ?\nComment les coûts des traitements varient-ils selon les pays ?",
"url": "https://questionsmedicales.fr/mesh/D003365?mesh_terms=Visual+Acuity&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Coûts et analyse des coûts",
"description": "Comment les complications augmentent-elles les coûts ?\nQuels types de complications sont les plus coûteux ?\nComment évaluer le coût des complications post-opératoires ?\nLes complications affectent-elles l'assurance santé ?\nComment prévenir les complications pour réduire les coûts ?",
"url": "https://questionsmedicales.fr/mesh/D003365?mesh_terms=Visual+Acuity&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Coûts et analyse des coûts",
"description": "Quels facteurs de risque augmentent les coûts de santé ?\nComment les facteurs socio-économiques influencent-ils les coûts ?\nLes antécédents familiaux influencent-ils les coûts ?\nComment les comportements de santé affectent-ils les coûts ?\nQuels facteurs environnementaux influencent les coûts de santé ?",
"url": "https://questionsmedicales.fr/mesh/D003365?mesh_terms=Visual+Acuity&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer les coûts d'un diagnostic médical ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les coûts incluent les tests, consultations et traitements associés au diagnostic."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent le coût d'un diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent la complexité du test, le lieu de réalisation et les ressources nécessaires."
}
},
{
"@type": "Question",
"name": "Quelles sont les méthodes d'analyse des coûts ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les méthodes incluent l'analyse coût-efficacité, coût-utilité et coût-minimisation."
}
},
{
"@type": "Question",
"name": "Comment les coûts de diagnostic varient-ils selon les régions ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les coûts peuvent varier en fonction des infrastructures de santé et des politiques locales."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des technologies sur les coûts de diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les nouvelles technologies peuvent réduire les coûts ou augmenter les dépenses initiales."
}
},
{
"@type": "Question",
"name": "Les symptômes influencent-ils les coûts des soins ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes plus graves peuvent entraîner des coûts de traitement plus élevés."
}
},
{
"@type": "Question",
"name": "Comment évaluer le coût des symptômes chroniques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il faut considérer les soins continus, les médicaments et les consultations régulières."
}
},
{
"@type": "Question",
"name": "Quels symptômes entraînent des coûts élevés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes liés à des maladies complexes comme le cancer ou les maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Les symptômes psychologiques augmentent-ils les coûts ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles mentaux peuvent nécessiter des traitements coûteux et prolongés."
}
},
{
"@type": "Question",
"name": "Comment les symptômes affectent-ils la productivité ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes persistants peuvent réduire la productivité, augmentant ainsi les coûts indirects."
}
},
{
"@type": "Question",
"name": "Quels sont les coûts des programmes de prévention ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les coûts incluent la sensibilisation, les vaccinations et les dépistages réguliers."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité économique de la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "On compare les coûts de prévention aux économies réalisées en évitant des traitements futurs."
}
},
{
"@type": "Question",
"name": "Quels programmes de prévention sont les plus rentables ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les programmes de vaccination et de dépistage précoce montrent souvent un bon rapport coût-efficacité."
}
},
{
"@type": "Question",
"name": "Comment la prévention impacte-t-elle les coûts de santé ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne prévention peut réduire les hospitalisations et les traitements coûteux à long terme."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent le coût des initiatives préventives ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent la portée du programme, les ressources nécessaires et l'engagement communautaire."
}
},
{
"@type": "Question",
"name": "Comment analyser les coûts des traitements médicaux ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il faut inclure les coûts des médicaments, des procédures et des soins associés."
}
},
{
"@type": "Question",
"name": "Quels traitements sont les plus coûteux ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements pour les maladies complexes comme le cancer ou les soins intensifs."
}
},
{
"@type": "Question",
"name": "Comment les traitements préventifs influencent-ils les coûts ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements préventifs peuvent réduire les coûts à long terme en évitant des maladies."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des nouvelles thérapies sur les coûts ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les nouvelles thérapies peuvent être coûteuses mais potentiellement plus efficaces."
}
},
{
"@type": "Question",
"name": "Comment les coûts des traitements varient-ils selon les pays ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les coûts varient en fonction des systèmes de santé, des politiques et des ressources disponibles."
}
},
{
"@type": "Question",
"name": "Comment les complications augmentent-elles les coûts ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent souvent des traitements supplémentaires et des soins prolongés."
}
},
{
"@type": "Question",
"name": "Quels types de complications sont les plus coûteux ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications liées aux maladies chroniques comme le diabète ou les maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Comment évaluer le coût des complications post-opératoires ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il faut inclure les soins supplémentaires, les hospitalisations et les traitements nécessaires."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles l'assurance santé ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent augmenter les primes d'assurance et les coûts pour les patients."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications pour réduire les coûts ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention par des soins appropriés et un suivi régulier peut réduire les complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque augmentent les coûts de santé ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs comme l'obésité, le tabagisme et le manque d'exercice augmentent les coûts."
}
},
{
"@type": "Question",
"name": "Comment les facteurs socio-économiques influencent-ils les coûts ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes à faible revenu peuvent avoir des coûts de santé plus élevés en raison d'un accès limité."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils les coûts ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies peuvent entraîner des coûts de prévention et de traitement plus élevés."
}
},
{
"@type": "Question",
"name": "Comment les comportements de santé affectent-ils les coûts ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des comportements sains peuvent réduire les coûts en diminuant le risque de maladies."
}
},
{
"@type": "Question",
"name": "Quels facteurs environnementaux influencent les coûts de santé ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pollution et les conditions de vie peuvent augmenter les risques de maladies et les coûts associés."
}
}
]
}
]
}
Visual outcomes after primary tumour treatment of uveal melanoma (UM) have been investigated repeatedly. This study evaluates the correlation between best-corrected visual acuity (BCVA) before treatme...
Pre-treatment BCVA was examined in relation to tumour dimensions and location, and survival in a retrospective cohort of 1809 patients who underwent plaque brachytherapy. BCVA was also correlated to t...
The mean BCVA of the tumour eye prior to plaque brachytherapy was LogMAR 0.42 (SD 0.46). Patients with low BCVA (LogMAR ≥ 1.00) did not differ in age (p = 0.19) and had similar frequency of ciliary bo...
UM patients with low BCVA before primary tumour treatment have a worse prognosis, likely related to increased tumour dimensions. Future studies should examine the prognostic significance of BCVA in re...
To investigate the association of macular optical coherence tomography (OCT)/OCT angiography (OCTA) parameters with visual acuity (VA) in glaucoma....
144 pseudophakic primary open-angle glaucoma eyes were included. Foveal (fVD), parafoveal (pf), perifoveal (perifVD) and whole-image vessel densities (wiVD) of superficial and deep layers, and their c...
In early glaucoma (80 eyes), no parameter correlated with VA. In moderate-advanced glaucoma (64 eyes), greater FAZ area (β=0.228) and circumference (β=0.063) correlated with worse VA (p<0.05), but not...
Some macular OCT/OCTA parameters were associated with VA in moderate-advanced, but not early glaucoma. These structural parameters may help identify glaucoma patients with impaired vision and reduced ...
NCT00221897....
Successful aging among independent community-dwelling older adults and those in residential settings is paramount to aging in place. The purpose of the current study was to explore how sensory, cognit...
Retinoblastoma (RB) and its associated treatments can significantly impact visual acuity. However, little is known regarding other measures of vision, such as contrast sensitivity or saccades. The aim...
This cross-sectional study included children aged 5-17 years who had completed treatment for RB. Visual acuity, saccades via fixation analysis, and contrast sensitivity by Cardiff contrast sensitivity...
Eleven children were enrolled (mean age, 10.7 ± 3.9 years). Treatment included enucleation (8 children [73%]) and chemotherapy (10 [91%]). Of the 11, one participant was unable to complete testing of ...
Decreased contrast sensitivity and impaired saccades were universally observed in this cohort of RB survivors. Comprehensive visual evaluation should be considered for all RB survivors to provide opti...
One of the characteristics of children with cerebral visual impairments (CVI) is that they need more time to process visual information. However, currently, few tests are available that can reliably m...
To evaluate the causative and risk factors for optic neuropathy with mucocele via imaging studies....
We included 21 patients with rhinogenous optic neuropathy with mucocele. We collected data on the sinus involved, age, sex, number of days from the onset of visual impairment to surgery, and computed ...
After surgery, visual acuity improved in 16/21 (76.2%) patients, and a correlation analysis showed a significant positive correlation between pre-operative and post-operative visual acuity. In imaging...
Imaging studies of optic neuropathy with mucocele help to determine the risk factors and perform early and precise diagnostic imaging and decision-making for surgery....
This study investigated the long-term visual acuity (VA) outcome in the eyes of children with uveitis and severe visual impairment (SVI; VA ≤ 20/200) at presentation. Fifty-one children [57 eyes; medi...
Despite advances in surgical techniques, cataract remains the leading cause of preventable blindness, and massive surgeries have been adopted as a strategy to change this situation. Monitoring the res...
This is a prospective and longitudinal study in which translation, cultural adaptation and validation of the visual function (VF) and quality of life (QoL) questionnaire were performed. The appearance...
VF and QoL questionnaires showed one-dimension, good values of TLI (0.973, 0.951) and SRMR (0.057, 0.054), and for each item, weights > 0.7, H2 > 0.5, ranges > 5.8 and the RMSEA < 0.08. Correlations f...
The cataract surgery outcomes are outside the WHO recommendations regarding VA, but they have had a great impact on improving VF and QoL. The questionnaires showed excellent psychometric properties an...
We make use of expected information gain to quantify the amount of knowledge obtained from measurements in a population. In the first application, we compared the expected information gain in the Snel...